financetom
Business
financetom
/
Business
/
Teradata Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Teradata Q3 Adjusted Earnings, Revenue Rise
Nov 5, 2024 2:00 AM

04:26 AM EST, 11/05/2024 (MT Newswires) -- Teradata ( TDC ) reported late Monday Q3 adjusted earnings of $0.69 per diluted share, up from $0.42 a year earlier.

Analysts polled by Capital IQ expected $0.56.

Revenue for the quarter ended Sept. 30 was $440 million, up from $438 million a year earlier.

Analysts polled by Capital IQ expected $417.7 million.

The company expects Q4 adjusted earnings of $0.40 to $0.44 per share. Analysts polled by Capital IQ are expecting $0.42.

The company now expects 2024 adjusted earnings of $2.30 to $2.34 per share, compared with previous guidance of $2.20 to $2.26 per share. Analysts polled by Capital IQ expect $2.28.

Price: 31.53, Change: -1.85, Percent Change: -5.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Microsoft-backed OpenAI Drops Foundry Plans; Partners With Broadcom, TSMC to Build AI Chips
Market Chatter: Microsoft-backed OpenAI Drops Foundry Plans; Partners With Broadcom, TSMC to Build AI Chips
Nov 3, 2024
01:10 PM EDT, 10/29/2024 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is working with Broadcom ( AVGO ) and TSMC (TSM) to build a chip designed to support artificial intelligence systems, Reuters reported Tuesday, citing sources. The company behind ChatGPT had planned to build its own foundries to manufacture chips but has foregone those plans due to the...
Zai Lab's Schizophrenia Treatment KarXT Meets Primary Endpoint in Phase 3 Trial
Zai Lab's Schizophrenia Treatment KarXT Meets Primary Endpoint in Phase 3 Trial
Nov 3, 2024
01:10 PM EDT, 10/29/2024 (MT Newswires) -- Zai Lab ( ZLAB ) said Tuesday that a phase 3 trial evaluating the safety and efficacy of KarXT in patients with schizophrenia in China met its primary endpoint as it demonstrated a statistically significant reduction in Positive and Negative Syndrome Scale total score compared with placebo at week 5. The trial, which...
--Street Color: OpenAI Works With Broadcom, TSMC to Produce Chip to Support AI Systems, Reuters Reports
--Street Color: OpenAI Works With Broadcom, TSMC to Produce Chip to Support AI Systems, Reuters Reports
Nov 3, 2024
01:10 PM EDT, 10/29/2024 (MT Newswires) -- Price: 178.34, Change: +6.32, Percent Change: +3.67 ...
CME Group Insider Sold Shares Worth $312,056, According to a Recent SEC Filing
CME Group Insider Sold Shares Worth $312,056, According to a Recent SEC Filing
Nov 3, 2024
01:08 PM EDT, 10/29/2024 (MT Newswires) -- Timothy Francis McCourt, Sr MD Global Head Equity & FX, on Oct. 28, 2024, sold 1,374 shares in CME Group ( CME ) for $312,056. Following the Form 4 filing with the SEC, McCourt has control over a total of 7,275 shares of the company, with 7,275 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1156375/000115637524000189/xslF345X05/wk-form4_1730220962.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved